Skip to main content
. 2015 Oct 16;15:722. doi: 10.1186/s12885-015-1778-8

Table 3.

Multivariate analysis of risk factors of EFS and OS of DLBCL patients treated with CHOP

Relative risk 95 % Cl P
EFS
 P-p38+ 2.54 1.01–6.4 <0.05
 Bcl-2+ 2.26 1.04–7.21 <0.05
 ABC 1.69 1.07–3.63 <0.05
OS
 P-p38+ 2.93 1.13–7.5 <0.05
 Bcl-2+ 3.33 1.28–6.63 <0.05
 ABC 2.45 1.68–4.56 <0.05

Cl Confidence intervals, EFS event-free survival, OS overall survival